Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rivka R Colen

Showing results (71-80 of 109) with videos related to

Pageof 11
Sort By:
Practical Radiation Oncology|December 30, 2014
Prospective observer and software-based assessment of magnetic resonance imaging quality in head and neck cancer: Should standard positioning and immobilization be required for radiation therapy applications?Yao Ding, Abdallah S R Mohamed, Jinzhong Yang, et al.
Oral Oncology|December 3, 2014
Characteristics and kinetics of cervical lymph node regression after radiation therapy for human papillomavirus-associated oropharyngeal carcinoma: quantitative image analysis of post-radiotherapy responseChad Tang, Clifton D Fuller, Adam S Garden, et al.
Journal for Immunotherapy of Cancer|July 28, 2021
Author response to Cunha <i>et al</i>Rivka R Colen, Christian Rolfo, Murat Ak, et al.
Nature Communications|July 20, 2019
Multicenter study demonstrates radiomic features derived from magnetic resonance perfusion images identify pseudoprogression in glioblastomaNabil Elshafeey, Aikaterini Kotrotsou, Ahmed Hassan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 22, 2014
Beam path toxicity in candidate organs-at-risk: assessment of radiation emetogenesis for patients receiving head and neck intensity modulated radiotherapyEsengul Kocak-Uzel, G Brandon Gunn, Rivka R Colen, et al.
Journal for Immunotherapy of Cancer|April 14, 2021
Radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancersRivka R Colen, Christian Rolfo, Murat Ak, et al.
Journal of Neuro-Oncology|July 14, 2016
A randomized phase II trial of standard dose bevacizumab versus low dose bevacizumab plus lomustine (CCNU) in adults with recurrent glioblastomaShiao-Pei Weathers, Xiaosi Han, Diane D Liu, et al.
Frontiers in Oncology|October 26, 2023
TP53-PTEN-NF1 depletion in human brain organoids produces a glioma phenotype <i>in vitro</i>Sanjay K Singh, Yan Wang, Ahmed Habib, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 24, 2017
CD90 Expression Controls Migration and Predicts Dasatinib Response in GlioblastomaTony Avril, Amandine Etcheverry, Raphaël Pineau, et al.
Journal of Immunotherapy and Precision Oncology|June 6, 2022
Selinexor in Combination with Carboplatin and Pemetrexed in Patients with Advanced or Metastatic Solid Tumors: Results of an Open-Label, Single-Center, Multi-Arm Phase 1b StudyKyaw Z Thein, Siqing Fu, Filip Janku, et al.
Pageof 11

Showing results (71-80 of 109) with videos related to

Sort By:
Pageof 11
Practical Radiation Oncology|December 30, 2014
Prospective observer and software-based assessment of magnetic resonance imaging quality in head and neck cancer: Should standard positioning and immobilization be required for radiation therapy applications?Yao Ding, Abdallah S R Mohamed, Jinzhong Yang, et al.
Oral Oncology|December 3, 2014
Characteristics and kinetics of cervical lymph node regression after radiation therapy for human papillomavirus-associated oropharyngeal carcinoma: quantitative image analysis of post-radiotherapy responseChad Tang, Clifton D Fuller, Adam S Garden, et al.
Journal for Immunotherapy of Cancer|July 28, 2021
Author response to Cunha <i>et al</i>Rivka R Colen, Christian Rolfo, Murat Ak, et al.
Nature Communications|July 20, 2019
Multicenter study demonstrates radiomic features derived from magnetic resonance perfusion images identify pseudoprogression in glioblastomaNabil Elshafeey, Aikaterini Kotrotsou, Ahmed Hassan, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|April 22, 2014
Beam path toxicity in candidate organs-at-risk: assessment of radiation emetogenesis for patients receiving head and neck intensity modulated radiotherapyEsengul Kocak-Uzel, G Brandon Gunn, Rivka R Colen, et al.
Journal for Immunotherapy of Cancer|April 14, 2021
Radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancersRivka R Colen, Christian Rolfo, Murat Ak, et al.
Journal of Neuro-Oncology|July 14, 2016
A randomized phase II trial of standard dose bevacizumab versus low dose bevacizumab plus lomustine (CCNU) in adults with recurrent glioblastomaShiao-Pei Weathers, Xiaosi Han, Diane D Liu, et al.
Frontiers in Oncology|October 26, 2023
TP53-PTEN-NF1 depletion in human brain organoids produces a glioma phenotype <i>in vitro</i>Sanjay K Singh, Yan Wang, Ahmed Habib, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 24, 2017
CD90 Expression Controls Migration and Predicts Dasatinib Response in GlioblastomaTony Avril, Amandine Etcheverry, Raphaël Pineau, et al.
Journal of Immunotherapy and Precision Oncology|June 6, 2022
Selinexor in Combination with Carboplatin and Pemetrexed in Patients with Advanced or Metastatic Solid Tumors: Results of an Open-Label, Single-Center, Multi-Arm Phase 1b StudyKyaw Z Thein, Siqing Fu, Filip Janku, et al.
Pageof 11